Linked Life Data

18297679

Source:http://linkedlifedata.com/resource/pubmed/id/18297679

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-2-28
pubmed:abstractText
Malaria continues to be a potentially fatal threat to almost half of the world's population. In light of this threat, the armory to fight this disease is rather limited. Resistance against the most common and affordable antimalarials is widespread. Only few new drugs are in clinical development, most of them belong to long used classes of antimalarial drugs. This review will concisely cover the drugs which are currently in use, and describe the drug candidates which are in clinical evaluation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0365-6233
pubmed:author
pubmed:issnType
Print
pubmed:volume
341
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
149-63
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Antimalarial drugs - what is in use and what is in the pipeline.
pubmed:affiliation
Philipps-Universität, Institut für Pharmazeutische Chemie, Marburg, Germany. martin.schlitzer@staff.uni-marburg.de
pubmed:publicationType
Journal Article, Review